IDEXX Laboratories Inc (IDXX)
Working capital turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 3,660,950 | 3,367,320 | 3,215,360 | 2,706,660 | 2,406,910 |
Total current assets | US$ in thousands | 1,495,250 | 1,101,480 | 955,655 | 1,062,740 | 679,639 |
Total current liabilities | US$ in thousands | 951,547 | 1,235,800 | 763,579 | 582,761 | 725,337 |
Working capital turnover | 6.73 | — | 16.74 | 5.64 | — |
December 31, 2023 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $3,660,950K ÷ ($1,495,250K – $951,547K)
= 6.73
The working capital turnover ratio is a measure of how efficiently a company is utilizing its working capital to generate sales revenue. Higher ratios indicate better efficiency in the management of working capital.
Based on the data provided for Idexx Laboratories, Inc., the working capital turnover ratio was 6.73 in 2023, 16.74 in 2021, and 5.64 in 2020. A higher working capital turnover ratio in 2021 suggests that the company was able to generate more revenue relative to its working capital investment compared to 2020. However, the absence of data for 2022 and 2019 limits a complete trend analysis.
Overall, the fluctuations in the working capital turnover ratio for Idexx Laboratories, Inc. indicate varying levels of efficiency in utilizing working capital to generate sales revenue over the years. It is crucial for the company to consistently monitor and manage its working capital effectively to optimize operational performance and financial health.
Peer comparison
Dec 31, 2023